Human trophoblasts consist of two main cell lineages, villous trophoblasts (VT) and extravillous trophoblasts (EVT). To identify the molecules which are involved in EVT differentiation, we have raised a monoclonal antibody (mAb) designated CHL1, by immunizing a mouse against human chorion laeve which is composed of EVT. By immunohistochemical analysis, the CHL1 antigen was found to be expressed on the majority of EVT but not on VT in addition to its expression on endothelial and myometrial cells. A subsequent cDNA panning method revealed that the CHL1 antigen was identical to melanoma cell adhesion molecule (MCAM, Mel-CAM, S-endo 1 or MUC18/CD146), which has been previously reported as one of the EVT markers. MCAM expression on JEG3 cells, a human choriocarcinoma-derived cell line, was signi®cantly enhanced when they were co-cultured with isolated human decidual tissue. Various cytokines and growth factors that were reportedly present in decidual tissue failed to increase MCAM expression in JEG3 cells, but decidua-induced MCAM expression in JEG3 cells was attenuated by the addition of protein kinase A inhibitor H89. In addition, cAMP, which is known to stimulate differentiation of VT, enhanced MCAM expression in JEG3 cells. Its promoting effect on MCAM expression was also observed in human chorionic villous explant cultures. These ®ndings suggest that a cAMP-dependent intracytoplasmic signalling pathway is involved in the differentiation mechanism of human EVT.
Introduction
During early placentation, human trophoblasts differentiate into two main cell lineages: villous and extravillous cells. Villous trophoblasts (VT) cover the chorionic villi of the placenta, and their function is to transport oxygen and nutrients from the mother to the fetus. In contrast, extravillous trophoblasts (EVT) invade the maternal endometrium and migrate up spiral arterioles in the uterine muscle layer. This process leads to the development of vessels with low resistance and high capacity, thereby enhancing blood¯ow to the intervillous space to meet the increasing fetal demands for nutrient and gas exchange (Pijnenborg et al., 1983) . These physiological changes are required for a successful pregnancy and failure of spiral artery transformation by EVT has been documented in pre-eclampsia and intrauterine growth retardation (Robertson, 1976) . EVT invade and migrate through maternal decidua and degrade extracellular matrix (ECM) of the arterial wall during arterial transformation, a process resembling tumour invasion (Aplin, 1991) . With this in mind, the roles of adhesion molecules, including integrins and ECM degrading enzymes such as metalloproteinases, on EVT invasion have been extensively investigated (Librach et al., 1991; Damsky et al., 1994) . However, unlike tumour invasion, EVT invasion is strictly regulated. For example, EVT invade the maternal decidua and myometria but do not exceed one-third of the myometrial layer. In addition, the invasiveness of EVT observed in early pregnancy ceases as the pregnancy proceeds (Pijnenborg et al., 1983) . Although previous investigations proposed the involvement of integrins and proteinases in the initiation of EVT invasion, the mechanisms that control EVT invasion in the deep portion have not yet been clari®ed.
To investigate regulatory mechanisms for EVT invasion, we have been focusing on molecules which are expressed on human EVT. Previously, we reported that CD9, a cell surface molecule which is known to be associated with b integrins, was predominantly expressed on human EVT. CD9 was also expressed on a choriocarcinomaderived cell line BeWo in association with integrin a5b1 and it was shown to regulate BeWo cell invasion (Hirano et al., 1999a; b) . In addition, a membrane-bound peptidase, dipeptidyl peptidase-IV/ CD26, was shown to be expressed on EVT and it could regulate the invasive property of another choriocarcinoma cell line, JEG3 (Sato gag044 Molecular Human Reproduction Vol.9, No.6 pp. 359±366, 2003 DOI: 10.1093 ã European Society of Human Reproduction and Embryology et al., 2002) . These ®ndings suggested that it is important to analyse molecules expressed on EVT when we investigate the function of the EVT, and thus we attempted to identify novel molecules that are expressed on human EVT. Previously, we have raised monoclonal antibodies (mAb) against ovarian cells and identi®ed several molecules that are involved in folliculogenesis and corpus luteum formation (Yamada et al., 1998a; b; Higuchi et al., 1999) . In the present study, we have raised mAb against human chorion laeve, which contains EVT expressing CD9 and dipeptidyl peptidase-IV. Among the mAb that reacted with the antigens on EVT, one mAb, named CHL1, was selected since expression of the CHL1 antigen in trophoblasts was con®ned to cells of extravillous lineage. Next, to identify a cDNA clone which encodes the CHL1 antigen, we constructed a cDNA library derived from human chorion laeve and subsequent panning analysis revealed that the CHL1 antigen is identical to the melanoma cell adhesion molecule (MCAM/CD146). MCAM is reported to be a membrane-bound glycoprotein which mediates cell±cell adhesion and has been shown to be expressed in a variety of normal human tissues and malignant neoplasms (Lehmann et al., 1987; Shih et al., 1994) . In human placenta, it was reported that the expression of MCAM is con®ned to the EVT (Shih and Kurman, 1996) and its role in implantation as well as placentation has been suggested (Shih et al., 1998) . However, the key factors which regulate the expression of MCAM in human EVT remain unclear. Since MCAM is considered an excellent marker for EVT, we further examined factors which regulate MCAM expression as this may provide information on the differentiation mechanisms of human EVT.
Materials and methods

Tissues
Placental tissues were obtained from ®rst-trimester pregnancies (6±12 weeks gestation, n = 6), including three cases of legally terminated pregnancies and three cases of hysterectomies for cervical intra-epithelial neoplasia during normal pregnancy. Term placentae (n = 5) and fetal membranes (n = 5) were obtained from normal deliveries. For RNA isolation, tissues were immediately frozen in liquid nitrogen and stored at ±80°C. For immunohistochemistry, each specimen was embedded in OCT compound (Tissue-Tec, Miles Inc., Diagnostic Division, USA), snap-frozen in liquid nitrogen, and stored at ±80°C. Informed consent for the use of these tissues in this study was obtained from all donors.
Production and selection of mAb
The production and selection of mAb were performed as described previously (Fujiwara et al., 1993; Higuchi, et al., 1999) . The chorion laeve from fetal membrane was manually separated and cut into small pieces using scissors, and was then injected into the peritoneal cavity of 8-week-old BALB/c mice four times every 4 weeks. On the 5th day after the last immunization, the spleen cells of the mice were fused with X63Ag8 myeloma cells and cultured in 96-well microtitre plates. Supernatants from the growing hybridomas were screened by indirect immuno¯uorescence staining on frozen sections of fetal membrane and term placenta. Hybridomas of interest were cloned, expanded, and injected i.p. into female mice previously treated with pristane (2,6,10,14-tetramethylpentadecane; Aldrich, USA). The immunoglobulin fraction was puri®ed from ascitic uid with Af®-gel protein A (Bio-Rad Laboratories, USA).
Antibodies
To con®rm speci®c immunoreactivity of the CHL1 mAb with MCAM, a commercially available mouse anti-human CD146/MCAM mAb (S-Endo1, IgG1; Alexis Biochemicals, USA) (Bardin et al., 1996) was used in immunohistochemistry. Fluorescein isothiocyanate (FITC)-conjugated mouse anti-human cytokeratin 8/18 mAb (5D3, IgG1; YLEM, Italy) was used in the immunohistochemical study as a marker for epithelial cells and trophoblasts.
For the immunochemistry and¯ow cytometry, an anti-trinitrophenyl (TNP) mouse mAb (unrelated mAb, IgG1) (Tsujimura et al., 1990) was used as the negative control. Rhodamine-conjugated goat anti-mouse immunoglobulin polyclonal antibody (pAb) (Santa Cruz Biotechnology Inc., USA) was used as the secondary antibody.
Immuno¯uorescence localization
Placental tissues were processed for immuno¯uorescence double staining as previously described (Fujiwara et al., 1993) with a slight modi®cation. Frozen tissues of 7 mm thickness were air-dried on Neoprene-coated glass slides (Nisshin EM, Japan), and ®xed in acetone at ±20°C for 5 min. The slides were incubated with CHL1 mAb (5 mg/ml, diluted in culture medium), S-Endo1 mAb (5 mg/ml), or anti-TNP mAb (5 mg/ml) for 40 min at room temperature. They were then washed in phosphate-buffered saline (PBS), and incubated with the rhodamine-conjugated secondary antibody (diluted 1:40) for 40 min at room temperature in the dark. After an incubation with anti-TNP mAb (20 mg/ml) to block non-speci®c binding, the slides were reacted with FITC-conjugated antihuman cytokeratin mAb (diluted 1:20) for 40 min. The slides were then washed and examined with a confocal laser scanning microscope (Carl Zeiss Inc., Germany) equipped with ®lters to view the rhodamine and isothiocyanatē uorescence.
cDNA library construction
A cDNA expression library was constructed as previously described with a slight modi®cation (Higuchi et al., 1999) . Poly (A)+ RNA was prepared from human chorion laeve, and cDNA was synthesized by priming with Not I oligo (dT) primer using a SuperScript Choice system (Invitrogen, The Netherlands) and ligated with BstXI adapter (Invitrogen). After digestion with Not I restriction enzyme, the cDNA was ligated into a BstXI-and Not I-digested pME18S mammalian cell expression plasmid vector, which carries a strong chimeric promoter of SV40 and SRa (Takebe et al., 1988) . The ligated plasmid DNA was transformed into Escherichia coli DH-5a by electroporation (Cell Porator System, Invitrogen). The cDNA library obtained contained 1Q10 6 clones.
Expression cloning of cDNA encoding the CHL1 antigen COS7 cells were obtained from the American Type Culture Collection and grown in Dulbecco's minimum essential medium/10% calf serum. The cDNA library was introduced into subcon¯uent COS7 cell cultures in 10 cm dishes by the N,N-Diethylaminoetyl (DEAE)±dextran transfection method. Detachment, treatment of transfected COS7 cells with CHL1 mAb, and recovery of plasmid DNA were carried out as previously described with a slight modi®cation (Higuchi et al., 1999) . Brie¯y, the CHL1 mAb-treated cells were resuspended in 1 ml PBS containing 0.5 mmol/l EDTA, 0.02% sodium azide and 5% fetal bovine serum (FBS). A 50 ml aliquot of sheep anti-mouse IgG-coated magnetic beads (Dynabeads; Dynal A. S., Norway) was added, and the cells incubated on ice for 30 min with periodic gentle shaking. After the CHL1 antigen-expressing cells coated with magnetic beads were recovered using a magnetic particle concentrator (Dynal), the episomal plasmid DNA was collected using the Hirt procedure (Hirt, 1967) and transformed into E. coli. The resulting colonies were pooled and ampli®ed in a liquid culture, and isolated plasmid DNA was subjected to the next cycle of transfection. After three rounds of transfection, ®nal selection of CHL1 antigen expressing COS7 cells was performed by a cell sorting method using CHL1 mAb (FACScan; Becton Dickinson Immunocytometry Systems Japan, Japan). The plasmids recovered from the sorted COS7 cells were then cloned and transfected again into COS7 cells. Each transfected cell was examined by¯ow cytometry with CHL1 mAb to con®rm CHL1 antigen expression. The cDNA insert of the selected plasmid clones was digested with Xho I, cloned into pBluescript SK (±), and veri®ed by sequencing (Higuchi et al., 1995) . This Xho I digested cDNA insert was also used as a probe for Northern blot analysis.
Immunoprecipitation and sodium dodecyl sulphate±polyacrylamide gel electrophoresis (SDS±PAGE)
Cell surface biotinylation was carried out as follows. COS7 cells transfected with CHL1 cDNA were washed with Hanks' balanced salt solution (HBSS) and incubated in a solution containing 150 mmol/l NaCl, 10 mmol/l HEPES, 0.2 mg/ml NHS-LC-Biotin (Pierce Chemical Co., USA), 0.2 mmol/l CaCl 2 and MgCl 2 , pH 8.0, for 30 min at 4°C. The reaction was stopped by the addition of 40 mmol/l glycine, and cells were washed with HBSS. Cells were then lysed with HEPES-buffered saline (HBS; 10 mmol/l HEPES, 150 mmol/l NaCl, pH 7.0) containing 10 mmol/l CHAPS, 10 mg/ml chymostatin, and 20 mg/ml antipain, and kept for 30 min at 4°C. The lysates were cleared of insoluble material by centrifugation, and the supernatant was immunoprecipitated with CHL1 mAb or TNP mAb at a concentration of 5 mg/ml followed by the addition of Dynabeads. The beads were washed with washing buffer (HBS containing 10 mmol/l CHAPS) and then boiled with SDS±PAGE sample buffer. Immunoprecipitates recovered were subjected to SDS±PAGE with 50 mmol/l dithiothreitol, and then electrotransferred to an Immobilon membrane (Bedford, USA). The membrane was blocked with 5% BSA in Trisbuffered saline, and biotinylated proteins were incubated with 100 ng/ml horseradish peroxidase±streptavidin (Pierce Chemical Co.) followed by detection with an ECL Western blotting kit (Amersham±Pharmacia, USA).
RNA isolation and Northern blot analysis
Total RNA from human fetal membrane, placenta, or cultured JEG3 were isolated by the TRIzol method (Invitrogen). Northern blot analysis was performed as previously reported (Higuchi et al., 1995) . In brief, 10 mg total RNA were electrophoresed on a 1.0% agarose±formaldehyde gel and then transferred to nylon membranes. The membranes were incubated with a prehybridization solution (Rapid Hyb; Amersham±Pharmacia) for 30 min at 65°C and hybridized for 2 h at 65°C with the labelled probes in the same solution. After hybridization, the ®lters were washed according to the manufacturer's protocol, and then subjected to autoradiography. To ensure even loading, the membranes were washed and rehybridized with a human ribosomal protein S26 cDNA probe, the expression level of which remains virtually constant in most tissues.
Cell lines and culture condition
JEG3, continuous cell lines established from a human choriocarcinoma, were obtained from the American Type Culture Collection (USA) and maintained in Roswell Park Memorial Hospital (RPMI) 1640 medium supplemented with 10% fetal calf serum, 100 IU/ml of penicillin and 100 mg/ml of streptomycin.
To examine the effects of decidual factors, 1Q10 6 JEG3 cells were suspended in 10 ml of complete medium and plated into each well of a 6-well culture plate (Corning Inc., USA). Decidual tissues were obtained from legally terminated pregnancies, and part of each tissue was histologically con®rmed as decidua. These decidual tissues were minced into pieces 5 mm in diameter and incubated in the cell culture insert (0.8 mm diameter pore: Becton Dickinson Labware, USA). JEG3 cells were cultured with these decidual tissue preparations for 2 days. As a control, chorionic tissue obtained from the same conceptus was placed into the cell cultures. JEG3 cells were also cocultured with decidual tissue for 2 days in the presence of a selective inhibitor of protein kinase A, H89 (20 and 50 mmol/l; Calbiochem-Novabiochem Co., USA) or vehicle alone (culture containing 0.5% dimethylsulphoxide). After the culture, JEG3 cells were subjected to¯ow cytometry or Northern blot analysis.
JEG3 cells were also cultured for 2 days in the presence of interleukin (IL)-1b, -4, -10, tumour necrosis factor (TNF)-a, interferon (IFN)-g (10 ng/ml each; Peprotech EC Ltd, UK), transforming growth factor (TGF)-b3 (10 ng/ml; Genzyme/Techne, USA) or forskolin (200 nmol/l; Sigma Chemical Co., USA), and then subjected to Northern blot analysis.
Human chorionic villous explant culture
Villous explant cultures were established using tissues from ®rst-trimester placentae (6±10 weeks of gestation, n = 3) as previously described with some modi®cations (Aplin et al., 1999) . Brie¯y, the placental tissues were placed in ice-cold RPMI and processed within 2 h of collection. The tissues were washed with sterile RPMI and aseptically dissected to remove decidual tissue. Small fragments of placental villi were teased apart, soaked in culture medium (RPMI supplemented with 10% fetal calf serum, 100 IU/ml of penicillin and 100 mg/ml of streptomycin), and placed into each well of a 6-well culture plate which had been precoated with porcine collagen type I (Koken Co. Ltd, Japan). These placental tissues were cultured for 48 h in the presence of 200 nmol/l forskolin or vehicle alone (culture containing 0.5% ethanol), and then subjected to Northern blot analysis.
Flow cytometry
The dispersed JEG3 cells (2Q10 5 ) were centrifuged and incubated at 4°C for 30 min with CHL1 mAb (100 mg/ml) or the anti-TNP mAb (negative control, 100 mg/ml). The cells were then washed twice with HBSS, and incubated with 20 ml of FITC-conjugated rabbit anti-mouse immunoglobulins (diluted to 1:40) at 4°C for 30 min in the dark. After washing in HBSS, the cells were resuspended in HBSS and analysed by FACScan.
Statistical analysis
Statistical differences between sample means were calculated by a two-tailed t-test. The results are expressed as means T SD of six independent experiments, and P < 0.05 was considered signi®cant.
Results
CHL1 antigen expression in human placentae
A murine mAb designated CHL1 (IgG1 isotype) was generated by immunizing mice with human EVT obtained from the chorion laeve of fetal membrane. Using this CHL1 mAb, immunohistochemical analysis was carried out to investigate the localization of CHL1 antigen in human placentae. Simultaneously, each placental section was immunostained with FITC-conjugated anti-human cytokeratin 8/18 mAb to identify trophoblasts and endometrial epithelial cells.
In ®rst trimester placentae, expression of the CHL1 antigen was observed on the majority of cytokeratin-positive EVT which had invaded into the maternal decidua: trophoblasts in the distal portion of cell columns, interstitial trophoblasts in the decidua, and on giant cells in the deep portion ( Figure 1A±C ). On the other hand, EVT in the proximal portion of cell columns did not express CHL1 antigen ( Figure 1B ). CHL1 antigen expression was not detected on the villous cytotrophoblasts or syncytiotrophoblasts ( Figure 1A ). No expression of CHL1 antigen was detected on decidual cells or endometrial epithelial cells, but myometrial cells and endothelial cells in the placental villi and maternal decidua did express CHL1 antigen ( Figure 1A±C ).
In second and third trimester placentae, the expression pro®les of CHL1 antigen were similar to that in ®rst trimester placentae. EVT in placentae of advanced gestation were observed as cytokeratin-positive scattered cells in the placental bed, where the CHL1 antigen was strongly expressed ( Figure 2C ). In the villi, CHL1 antigen expression was also observed on endothelial cells but not on cytotrophoblasts or syncytiotrophoblasts (Figure 2A and C) .
In the fetal membrane at term pregnancy, EVT were observed as a cytokeratin-positive multicellular layer, chorion laeve ( Figure 2B and D). CHL1 antigen was strongly expressed on EVT of the maternal portion in the chorion laeve, but not on the fetal portion ( Figure 2B and D). Amniotic epithelial cells and decidual cells were negative for CHL1 antigen expression.
In these immunohistochemical analyses of placentae and fetal membranes, no immunostaining was observed when anti-TNP mAb was used as the primary antibody (data not shown).
Identi®cation of CHL1 antigen as MCAM/CD146 antigen
cDNA clones encoding the CHL1 antigen were recovered from a chorion laeve cDNA library by mAb panning of transfected COS7 cells. After four successive rounds of mAb panning and plasmid retrieval, one plasmid clone pCHL1-12 showed cell surface expression of CHL1 antigen on COS7 cells as detected by¯ow cytometry (data not shown). Immunoprecipitation and electrophoresis showed a prominent band of material precipitated from pCHL1-12 transfected cAMP mediates extravillous trophoblast differentiation COS7 cells by CHL1 mAb (Figure 3, lane 1) . The calculated mean molecular mass was 110 kDa.
Plasmid clone pCHL1-12 was subjected to DNA sequencing, and comparison of the nucleotide sequences with the EMBL/GenBank databases showed that clone CHL1 was identical to the human melanoma cell adhesion molecule (MCAM/CD146 antigen) (Lehmann et al., 1989) .
Expression of MCAM mRNA in human placentae
MCAM mRNA was detected by Northern blotting as a transcript of 3.3 kb in human placentae as previously described (Lehmann et al., 1989) (Figure 4) . Expression of MCAM mRNA in placental tissue was variable from sample to sample, possibly re¯ecting the amount of MCAM-expressing endothelial cells in¯oating villi (Figure 4 , lanes 1±12). In addition, MCAM mRNA was observed as a single transcript in fetal membrane which contains EVT of chorion laeve (Figure 4 , lanes 13±16).
Enhancement of MCAM expression in JEG3 cells by decidual tissue
Under normal culture conditions, weak MCAM expression on the surface of JEG3 cells was detected by¯ow cytometry (data not shown). When JEG3 cells were cultured for 2 days in the presence of isolated decidual tissues, MCAM expression was enhanced as compared with the cells cultured under the presence of chorionic tissue derived from the same patients ( Figure 5A ). Northern blot analyses showed that this enhancement of MCAM expression was also observed at the transcriptional level ( Figure 5B ).
Increased cAMP levels enhance MCAM expression in JEG3 cells and in human chorionic villous explant cultures
To identify the decidua-derived factors which enhance MCAM expression in JEG3 cells, we examined the effects of several cytokines and growth factors which are known to be produced by decidual tissue. JEG3 cells were cultured for 48 h in the presence of IL-1b, IL-4, IL-10, TNF-a, TGFb3, or IFN-g, and expression of MCAM mRNA was examined by Northern blot analysis. The expression of MCAM mRNA was faint in JEG3 cells cultured under standard conditions ( Figure 6 , lane 1), however none of the cytokines or growth factors described above showed any enhancement of MCAM mRNA expression ( Figure 6 , lanes 2±7).
Next we examined the involvement of cAMP in decidua-induced MCAM expression in JEG3 cells because cAMP is reported to enhance MCAM expression in non-trophoblastic cells (Rummel et al., 1996) . In the presence of H89, a selective inhibitor for protein kinase A, decidua-induced MCAM expression in JEG3 cells was attenuated in a dose dependent manner (Figure 7) . Furthermore, forskolin, an activator of adenyl cyclase that leads to increased cAMP levels, signi®cantly enhanced the expression of MCAM mRNA in JEG3 ( Figure 8 ). To examine whether this stimulatory effect of cAMP on MCAM expression also functions in non-neoplastic human placental tissue, a human chorionic villous explant culture was carried out in the presence of forskolin. Northern blot analysis showed a signi®cant enhancement of MCAM mRNA expression in the explant culture with forskolin compared with that of vehicle alone (Figure 9 ).
Discussion
In the present study, we raised mAb against human EVT in chorion laeve and obtained a mAb, CHL1, which reacted with these cells. To identify a cDNA clone which encoded the CHL1 antigen, we constructed a cDNA library derived from human chorion laeve and subsequent panning analysis revealed that CHL1 antigen was identical to MCAM/CD146. MCAM is an integral membrane glycoprotein of 113 kDa which belongs to the immunoglobulin supergene family and was originally de®ned as a marker of tumour progression and metastasis formation in human melanoma (Lehmann et al., 1987) . MCAM expression has been detected in a variety of tissues (Lehmann et al., 1987; Shih et al., 1994; , and its speci®c expression on human EVT has already been described (Shih and Kurman, 1996) . Our immunohistochemical analyses using the CHL1 mAb showed intense MCAM expression on EVT lineage cells, which was compatible with the previous study (Shih and Kurman, 1996) . Comparison of MCAM expression with cytokeratin expression showed that MCAM was not expressed on EVT in the proximal portion of cell columns. In addition, expression of MCAM in the chorion laeve was observed in the maternal portion of EVT but not on the fetal portion. While trophoblasts in chorion laeve are considered as EVT, it has been reported that several stages of EVT differentiation exist in this layer. EVT located nearer the amniotic epithelium are proliferative and undifferentiated, while EVT nearer the decidua are nonproliferative and differentiated (Kaltenbach and Sachs, 1979) . From the results of our immunohistochemical analyses, including those with another available anti-MCAM mAb S-Endo1, MCAM appears to be expressed on EVT with relatively differentiated phenotypes. Therefore, we 1 and 3) or empty vector pME18S (lanes 2 and 4) were immunoprecipitated with CHL1 mAb (lanes 1 and 2) or with TNP mAb (lanes 3 and 4) . CHL1 antigen was observed as a single 110 kDa protein band in lane 1.
cAMP mediates extravillous trophoblast differentiation considered that MCAM is a sensitive marker which is useful to investigate the differentiation mechanism of EVT.
To investigate factors which regulate MCAM expression in human EVT, we used the choriocarcinoma-derived cell line JEG3 which expresses MCAM in addition to the expression of HLA-G, another speci®c marker of EVT (Kovats et al., 1990; Chumbley et al., 1993; . Using this JEG3 cell line, we examined the effects of isolated decidual tissues on MCAM expression in JEG3 cells because maternal decidua have direct contact with EVT during placentation, and a role for decidual tissues in the differentiation of trophoblasts has been proposed (Ren and Braunstein, 1991; Katsuragawa et al., 1995) . When JEG3 cells were co-cultured with decidual tissue, the expression of MCAM was enhanced. In previous reports, soluble factors from decidual tissues or decidualized endometrial stromal cells were shown to suppress trophoblastic production of hCG, which is a marker of villous trophoblastic differentiation (Ren and Braunstein, 1991; Katsuragawa et al., 1995) . Since the immunohistochemical analyses showed that MCAM was speci®cally expressed on EVT, our results support the concept that decidual tissues facilitate trophoblast differentiation into the extravillous lineage. As to the factors causing these effects, some soluble factors secreted from decidual tissues were thought to be important because this stimulatory effect on MCAM expression was observed without direct contact between the decidual tissues and JEG3 cells. To clarify such factors, we examined the expression of MCAM in JEG3 cells in the presence of several cytokines which are present in maternal decidua such as IL-1b, IL-4, IL-10, TNF-a, TGF-b3 and IFN-g (Saito et al., 1994; Piccinni et al., 1998; Ashkar and Croy, 1999; Bischof et al., 2000) . Unfortunately, we could not observe any signi®cant changes in MCAM mRNA expression with these cytokines. In addition, in our preliminary experiments, co-cultures with peripheral blood mononuclear cells also failed to induce MCAM expression on JEG-3 cells (data not shown). From these observations, we speculate that some soluble factors from decidual cells other than cytokines may be responsible for promoting EVT differentiation.
We also examined intracytoplasmic signalling factors which mediate MCAM expression. Several studies have demonstrated that Figure 4 . Expression of melanoma cell adhesion molecule (MCAM) mRNA during placental development. Aliquots (10 mg) of total RNA extracted from human placentae at ®rst trimester (lanes 1±4), second trimester (lanes 5±8), third trimester (lanes 9±12), and fetal membrane at third trimester of pregnancy (lanes 13±16) were analysed by Northern blot analysis using a MCAM cDNA probe (upper). As a control for the amount of RNA loaded, the ®lter was rehybridized with a human S26 ribosomal protein cDNA probe (lower). cAMP is involved in the regulation of MCAM expression in melanoma and neuroectodermal cells (Rummel et al., 1996) . In addition, the cAMP responsive element found in the MCAM promoter was shown to be a major transcriptional activator (Mintz and Johnson, 2000) . cAMP has been shown to stimulate hCG production in isolated human trophoblasts (Feinman et al., 1986) and various choriocarcinoma-derived cell lines (Hohn et al., 1998) . We have also observed that forskolin enhanced hCG production in JEG3 cells (data not shown). Since increased production of hCG is considered to be one of the characteristics of trophoblastic differentiation into the villous lineage, it is of interest whether cAMP induces or reduces MCAM expression of JEG-3 cells. In our study, the protein kinase A inhibitor H89 attenuated the decidua-induced MCAM expression in JEG3 cells. This suggests that the cAMP-dependent signalling pathway is involved in the regulation of MCAM expression in trophoblastic cancer cells, as observed in melanoma cells. Northern blot analysis clearly indicated that forskolin signi®cantly enhanced the expression of MCAM mRNA in JEG3 cells, supporting the above conclusion. Because MCAM is an excellent differentiation marker for EVT lineage cells, it is speculated that cAMP can induce trophoblastic differentiation into the extravillous lineage. To con®rm this idea, we examined the effects of forskolin on MCAM expression using a human chorionic villous explant culture system, which is thought to reproduce trophoblast differentiation occurring in the cell column (Aplin et al., 1999) . Northern blot analysis showed that the expression of MCAM mRNA was also enhanced in human chorionic villous explant culture by forskolin treatment. Considering our results together with the previous reports showing that cAMP induces trophoblast differentiation into the villous lineage, it appears that cAMP is involved in the differentiation of human trophoblasts into both villous and extravillous lineages. Since MCAM expression was observed in cells from a relatively differentiated stage of the EVT lineage, cAMP may be involved not in the initial step when selecting the VT or EVT pathway, but in the following steps after determing the EVT lineage.
In conclusion, this study provides evidence that decidua-derived factors enhance the expression of MCAM in JEG3 cells. As trophoblastic expression of MCAM was con®ned to the extravillous lineage, a possible role of decidua-derived factors in EVT differentiation is suggested. Although the decidua-derived factors have not yet been de®nitively shown, it is also suggested that a cAMP-dependent intracytoplasmic signalling pathway plays a role in this promotion process. Further studies using MCAM, an excellent marker for EVT, will contribute to clarifying the mechanism(s) which determines the differentiation pathway of trophoblasts. cAMP mediates extravillous trophoblast differentiation
